Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.

Approximately one in eight Americans are taking medications like Ozempic or Wegovy for weight loss, diabetes, heart disease ...

Viking Therapeutics completed enrollment of the VK2735 maintenance study in January and is set to report results in 3Q26.

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time.

Brooks Nader shared the plastic surgery procedure she was less-than-thrilled about after the fact, admitting that she "just ...

Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals ...

New research suggests the risks tied to early pregnancy exposure to popular weight loss drugs may not be the same for every patient.

Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...